Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001415889-23-000291

Options or other derivatives

  • CEO acquired 350,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Russo Rene CEO 2023-01-01 Grant or award · Stock Option (right to buy) +350,000 350,000 D
Loading xslF345X03/form4-01042023_090151.xml…